CGS 9343B
CAS: 109826-27-9
Ref. 3D-JEA82627
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Product Information
- 1-{1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)methyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
- 1-{1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)methyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one (2Z)-but-2-enedioate
- 2H-Benzimidazol-2-one, 1,3-dihydro-1-[1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)methyl]-4-piperidinyl]-, (Z)-2-butenedioate (1:1)
- 4H,6H-Pyrrolo[1,2-a][4,1]benzoxazepine, 2H-benzimidazol-2-one deriv.
- Cgs-9343B
- Kw-5617
- Zaldaride maleate
- Zy-17617B
CGS 9343B is a fatty acid that binds to calcium and calmodulin. It has been shown to have cytosolic calcium-dependent activity in skin cells, which may be due to its ability to induce the release of epidermal growth factor (EGF). CGS 9343B also inhibits atp levels and ATP-sensitive potassium channels in experimental models. This drug has been shown to inhibit the growth of diarrheal pathogens such as Clostridium difficile and Salmonella enterica.
Chemical properties
Technical inquiry about: 3D-JEA82627 CGS 9343B
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.